Source comparison
The Mechanistic Truth About CJC-1295 vs HGH Therapy
Here's the honest answer: CJC-1295 and recombinant HGH aren't interchangeable GH-boosting tools. They're mechanistically opposite interventions. One amplifies the body's own system; the other replaces it. Treating them as equivalent because both raise IGF-1 mi
This comparison does not assign a generated winner or score.
- Here's the honest answer: CJC-1295 and recombinant HGH aren't interchangeable GH-boosting tools. They're mechanistically opposite interventions. One amplifies the body's own system; the other replaces it. Treating them as equivalent because both raise IGF-1 misses the entire point. The pulsatile secretion pattern CJC-1295 preserves isn't a minor pharmacokinetic detail. It's the physiological architecture that prevents receptor desensitization, maintains insulin sensitivity, and allows endogenous capacity to survive long-term use. RhGH's sustained elevation produces faster, more dramatic effects, but it does so by shutting down the pituitary's ability to regulate itself. For research models where preserving natural GH rhythms matters. Aging studies, metabolic investigations, anything requiring multi-month timelines. CJC-1295 is the only mechanism that doesn't destroy what it's measuring. RhGH excels in short-term, high-precision anabolic studies where pharmacokinetic control outweighs f
- Real Peptides supplies both CJC-1295 with DAC and research-grade peptides across the GH secretagogue category. Every batch synthesized with exact amino-acid sequencing and third-party purity verification. The distinction between receptor-mediated amplification and direct hormone replacement isn't academic. It defines which biological systems remain functional at the end of your protocol.